More insurance plans than ever are offering Taltz as the Preferred IL-17A antagonist across Commercial and Part D.Learn more
FOR ADULT PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
Consider Taltz as your first-line biologic for patients like Taylor*
“I need to see improvement quickly, but I also need results to last over time.”
SELECT IMPORTANT SAFETY INFORMATION: CONTRAINDICATIONS
Taltz is contraindicated in patients with a previous serious hypersensitivity reaction, such as anaphylaxis, to ixekizumab or to any of the excipients.